The Zacks Analyst Blog Highlights KB Home, Interactive Brokers Group, Qualcomm and Johnson & Johnson
KB Home, Interactive Brokers Group, Qualcomm and Johnson & Johnson are part of the Zacks top Analyst Blog.…
16,410€
1,74%
Echtzeit-Aktienkurs Johnson Matthey PLC
Bid:
Ask:
Nachrichten zur Johnson Matthey PLC Aktie
4 Stocks to Watch on Their Recent Dividend Hikes
Stocks like KB Home (KBH), Interactive Brokers Group, Inc. (IBKR), QUALCOMM Incorporated (QCOM) and Johnson & Johnson (JNJ) recently hiked…
Johnson & Johnson: Kursziel reduziert
Toronto (www.aktiencheck.de) - Rating-Update:
Shagun Singh, Analyst von RBC Capital Markets, stuft die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046,…
Analyst updates Johnson & Johnson stock price target after earnings
This is what could happen next to Johnson & Johnson shares.…
Johnson & Johnson: Asymmetrische Risiken und attraktive Chancen - Aktienanalyse
London (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von HSBC:
HSBC rät in einer aktuellen Aktienanalyse zum Kauf der Aktie von Johnson &…
Cosmetics Market Analysis, Size, and Global Forecast Report 2023-2032 Featuring Coty, P&G, Estee Lauder, Colgate-Palmolive, Johnson & Johnson, Revlon, Beiersdorf, Kao, LVMH, and Mary Kay
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Cosmetics Market, Size, Global Forecast 2024-2032, Industry Trends, Growth, Share,…
Johnson & Johnson upgraded to Buy at HSBC on asymmetric risk and attractive upside By Investing.com
Johnson & Johnson upgraded to Buy at HSBC on asymmetric risk and attractive upside…
Johnson & Johnson: Kursziel gekappt
Charlotte (www.aktiencheck.de) - Rating-Update:
Geoff Meacham, Analyst von BofA Securities, stuft die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046, WKN:…
Johnson & Johnson: Buy This Bargain Before Its Gone
…
Top Stock Reports for NVIDIA, Alphabet & Johnson & Johnson
Todays Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Alphabet Inc. (GOOGL) and Johnson…
ASML überrascht negativ - Gemischte Zahlen von Johnson & Johnson - LVMH meldet schwächere Nachfrage
Wien (www.aktiencheck.de) - Johnson & Johnson (ISIN: US4781601046, WKN: 853260, Ticker-Symbol: JNJ, NYSE-Symbol: JNJ) (-2,1%), traditionell eines der ersten Unternehmen…
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
Johnson & Johnson (JNJ) continued with its long streak of earnings beat but lagged revenue estimates.…
Stifel cuts Johnson & Johnson stock target, maintains hold By Investing.com
Stifel cuts Johnson & Johnson stock target, maintains hold…
Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript
JNJ earnings call for the period ending March 31, 2024.…
Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript
…
J&Js first quarter profits top estimates on strong cancer drug sales
Johnson & Johnson (NYSE:JNJ) reported better-than-expected first quarter profits driven by strong sales of its cancer drugs, but shares of…
Johnson & Johnson: Punktlandung ohne große Aufregung - Aktienanalyse
Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…
UnitedHealth: Die Aktie steigt nach Ergebnissen zum ersten Quartal - Aktiennews
Frankfurt (www.aktiencheck.de) - UnitedHealth: Die Aktie steigt nach Ergebnissen zum ersten Quartal - Aktiennews
Heute haben zwei große US-Unternehmen, die mit…
Johnson & Johnson 2024 Q1 - Results - Earnings Call Presentation
…
Johnson & Johnson macht Milliardengewinn - Prognosen eingegrenzt
NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Medizintechnikkonzern Johnson & Johnson (J&J) hat im ersten Quartal von einem starken…
Johnson & Johnson posts mixed results, narrows full-year guidance By Investing.com
Johnson & Johnson posts mixed results, narrows full-year guidance…
Johnson & Johnson tops quarterly profit estimates as medical device sales jump
The company is benefiting from a rebound in demand for nonurgent surgeries among older adults, who deferred those procedures during the Covid pandemic.…
Johnson & Johnson: Durchmischte Zahlen – Aktie gibt nach
J&J übertrifft die Gewinnerwartungen, die Aktie fällt vorbörslich.…
J&J beats first-quarter profit estimates on cancer drugs strength
Johnson & Johnson reported a first-quarter profit above Wall Street estimates on Tuesday, helped by strong sales of its cancer…
Q1 24 S&P 500 Earnings (And Johnson & Johnson): Expecting Another Normal Earnings Season
…
Netflix, Johnson & Johnson, Procter & Gamble And Baidu On Watch
…
Johnson & Johnson: Doubling Down On This 2024 Dog Of The Dow
…
Johnson & Johnson expected to face dip in first-quarter earnings
Johnson & Johnson (NYSE:JNJ) will report first quarter results next Tuesday, 16 April, hot on the heels of its acquisition…
Rallybio partners with J&J to advance therapies targeting rare fetal disease
Rallybio announced it is collaborating with Johnson & Johnson (NYSE:JNJ) on the development of therapies aimed at reducing the risk…
Kenvue is assisted by Prevas’ expertise in project management and technology
During 2023, the pharmaceutical company Johnson & Johnson’s Consumer Business underwent a spin-off into a separate legal entity known as…
Johnson & Johnson Aktie: Prognose vor Quartalsbericht
Die Markterwartungen deuten darauf hin, dass Johnson & Johnson im Vergleich zum Vorjahr einen Rückgang der Gewinne bei niedrigeren Umsätzen…
Johnson & Johnson Aktie: Milliardenschwere Übernahme
Johnson & Johnson, eines der vielseitigsten Pharmaunternehmen mit großem Kapital, hat bekannt gegeben, dass es das Unternehmen für medizinische Geräte…
Johnson & Johnson wins FDA nod for Carvykti label expansion
…